Active pharmaceutical ingredients: development, manufacturing, and regulation
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
New York ; London
Informa Healthcare
[2010]
|
| Ausgabe: | Second edition |
| Schriftenreihe: | Drugs and the pharmaceutical sciences
Volume 205 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | xv, 433 Seiten Illustrationen, Diagramme 24 cm |
| ISBN: | 9781439803363 1439803366 |
Internformat
MARC
| LEADER | 00000nam a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV044741758 | ||
| 003 | DE-604 | ||
| 005 | 20180221 | ||
| 007 | t | ||
| 008 | 180201s2010 xxua||| |||| 00||| eng d | ||
| 010 | |a 2009034997 | ||
| 020 | |a 9781439803363 |c hb : alk. paper |9 978-1-4398-0336-3 | ||
| 020 | |a 1439803366 |c hb : alk. paper |9 1-439-80336-6 | ||
| 035 | |a (DE-599)BVBBV044741758 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c US | ||
| 049 | |a DE-M382 | ||
| 050 | 0 | |a RM301.25 | |
| 082 | 0 | |a 615/.19 | |
| 245 | 1 | 0 | |a Active pharmaceutical ingredients |b development, manufacturing, and regulation |c edited by Stanley H. Nusim |
| 250 | |a Second edition | ||
| 264 | 1 | |a New York ; London |b Informa Healthcare |c [2010] | |
| 264 | 4 | |c © 2010 | |
| 300 | |a xv, 433 Seiten |b Illustrationen, Diagramme |c 24 cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Drugs and the pharmaceutical sciences |v Volume 205 | |
| 505 | 8 | |a Literaturangaben und Index | |
| 650 | 4 | |a Drug development | |
| 650 | 4 | |a Pharmaceutical technology | |
| 650 | 4 | |a Drugs |x Law and legislation | |
| 650 | 4 | |a Pharmaceutical industry | |
| 650 | 4 | |a Drug Industry |x organization & administration | |
| 650 | 4 | |a Chemistry, Pharmaceutical | |
| 650 | 4 | |a Drug Compounding | |
| 650 | 4 | |a Legislation, Drug | |
| 650 | 4 | |a Legislation, Pharmacy | |
| 650 | 0 | 7 | |a Zulassung |0 (DE-588)4127410-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 0 | 1 | |a Zulassung |0 (DE-588)4127410-6 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 689 | 1 | 0 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 1 | |8 2\p |5 DE-604 | |
| 700 | 1 | |a Nusim, Stanley H. |4 edt | |
| 830 | 0 | |a Drugs and the pharmaceutical sciences |v Volume 205 |w (DE-604)BV000002008 |9 205 | |
| 856 | 4 | 2 | |m LoC Fremddatenuebernahme |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030137579&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030137579 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804178246594461696 |
|---|---|
| adam_text | ACTIVE PHARMACEUTICAL INGREDIENTS
/ NUSIM, STANLEY
: C2009
TABLE OF CONTENTS / INHALTSVERZEICHNIS
PROCESS DEVELOPMENT, SCALEUP & DESIGN / CARLOS B. ROSAS
TECHNOLOGY TRANSFER & FIRST MANUFACTURE / CARLOS B. ROSAS
PLANT DESIGN & CONSTRUCTION / STEVEN MONGIARDO
REGULATORY REQUIREMENTS? : REQUIREMENTS AND EXPECTATIONS / JOHN CURRAN
REGULATORY REQUIREMENTS : GUIDELINES AND EVOLVING STRATEGIES / JOHN
CURRAN
PROCESS VALIDATION / JAMES AGALLOCO, PHIL DESANTIS
QUALITY ASSURANCE & CONTROL / MICHAEL J. VANDER ZWAN, CARLOS YURASZECK
ENVIRONMENTAL CONTROL / BRUCE WALLINGTON
THERMOCHEMICAL PROCESS SAFETY / CARLOS B ROSAS
DESIGN AND OPERATING PRACTICES FOR SAFETY / STANLEY GROSSEL
PLANT OPERATIONS / STANLEY H NUSIM
STERILE BULK MANUFACTURING / JAMES AGALLOCO, PHIL DESANTIS
BIOLOGICAL MANUFACTURING / STEPHEN DREW, MAX J. KENNEDY, RANDOLPH L.
GREASHAM
SUPPLY MANAGEMENT / VICTOR CATALANO
PLANT MAINTENANCE / KAIZAD SUNAVALA.
DIESES SCHRIFTSTUECK WURDE MASCHINELL ERZEUGT.
|
| any_adam_object | 1 |
| author2 | Nusim, Stanley H. |
| author2_role | edt |
| author2_variant | s h n sh shn |
| author_facet | Nusim, Stanley H. |
| building | Verbundindex |
| bvnumber | BV044741758 |
| callnumber-first | R - Medicine |
| callnumber-label | RM301 |
| callnumber-raw | RM301.25 |
| callnumber-search | RM301.25 |
| callnumber-sort | RM 3301.25 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| contents | Literaturangaben und Index |
| ctrlnum | (DE-599)BVBBV044741758 |
| dewey-full | 615/.19 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.19 |
| dewey-search | 615/.19 |
| dewey-sort | 3615 219 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | Second edition |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02398nam a2200601zcb4500</leader><controlfield tag="001">BV044741758</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20180221 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">180201s2010 xxua||| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2009034997</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781439803363</subfield><subfield code="c">hb : alk. paper</subfield><subfield code="9">978-1-4398-0336-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1439803366</subfield><subfield code="c">hb : alk. paper</subfield><subfield code="9">1-439-80336-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044741758</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-M382</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM301.25</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.19</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Active pharmaceutical ingredients</subfield><subfield code="b">development, manufacturing, and regulation</subfield><subfield code="c">edited by Stanley H. Nusim</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">Second edition</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York ; London</subfield><subfield code="b">Informa Healthcare</subfield><subfield code="c">[2010]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xv, 433 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield><subfield code="c">24 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Drugs and the pharmaceutical sciences</subfield><subfield code="v">Volume 205</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Literaturangaben und Index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug development</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical technology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Law and legislation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="x">organization & administration</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chemistry, Pharmaceutical</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Compounding</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Legislation, Drug</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Legislation, Pharmacy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nusim, Stanley H.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Drugs and the pharmaceutical sciences</subfield><subfield code="v">Volume 205</subfield><subfield code="w">(DE-604)BV000002008</subfield><subfield code="9">205</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">LoC Fremddatenuebernahme</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030137579&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030137579</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| id | DE-604.BV044741758 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T08:00:55Z |
| institution | BVB |
| isbn | 9781439803363 1439803366 |
| language | English |
| lccn | 2009034997 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030137579 |
| open_access_boolean | |
| owner | DE-M382 |
| owner_facet | DE-M382 |
| physical | xv, 433 Seiten Illustrationen, Diagramme 24 cm |
| publishDate | 2010 |
| publishDateSearch | 2010 |
| publishDateSort | 2010 |
| publisher | Informa Healthcare |
| record_format | marc |
| series | Drugs and the pharmaceutical sciences |
| series2 | Drugs and the pharmaceutical sciences |
| spelling | Active pharmaceutical ingredients development, manufacturing, and regulation edited by Stanley H. Nusim Second edition New York ; London Informa Healthcare [2010] © 2010 xv, 433 Seiten Illustrationen, Diagramme 24 cm txt rdacontent n rdamedia nc rdacarrier Drugs and the pharmaceutical sciences Volume 205 Literaturangaben und Index Drug development Pharmaceutical technology Drugs Law and legislation Pharmaceutical industry Drug Industry organization & administration Chemistry, Pharmaceutical Drug Compounding Legislation, Drug Legislation, Pharmacy Zulassung (DE-588)4127410-6 gnd rswk-swf Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Arzneimittel (DE-588)4003115-9 s Zulassung (DE-588)4127410-6 s 1\p DE-604 Arzneimittelentwicklung (DE-588)4143176-5 s 2\p DE-604 Nusim, Stanley H. edt Drugs and the pharmaceutical sciences Volume 205 (DE-604)BV000002008 205 LoC Fremddatenuebernahme application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030137579&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Active pharmaceutical ingredients development, manufacturing, and regulation Drugs and the pharmaceutical sciences Literaturangaben und Index Drug development Pharmaceutical technology Drugs Law and legislation Pharmaceutical industry Drug Industry organization & administration Chemistry, Pharmaceutical Drug Compounding Legislation, Drug Legislation, Pharmacy Zulassung (DE-588)4127410-6 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd Arzneimittel (DE-588)4003115-9 gnd |
| subject_GND | (DE-588)4127410-6 (DE-588)4143176-5 (DE-588)4003115-9 |
| title | Active pharmaceutical ingredients development, manufacturing, and regulation |
| title_auth | Active pharmaceutical ingredients development, manufacturing, and regulation |
| title_exact_search | Active pharmaceutical ingredients development, manufacturing, and regulation |
| title_full | Active pharmaceutical ingredients development, manufacturing, and regulation edited by Stanley H. Nusim |
| title_fullStr | Active pharmaceutical ingredients development, manufacturing, and regulation edited by Stanley H. Nusim |
| title_full_unstemmed | Active pharmaceutical ingredients development, manufacturing, and regulation edited by Stanley H. Nusim |
| title_short | Active pharmaceutical ingredients |
| title_sort | active pharmaceutical ingredients development manufacturing and regulation |
| title_sub | development, manufacturing, and regulation |
| topic | Drug development Pharmaceutical technology Drugs Law and legislation Pharmaceutical industry Drug Industry organization & administration Chemistry, Pharmaceutical Drug Compounding Legislation, Drug Legislation, Pharmacy Zulassung (DE-588)4127410-6 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd Arzneimittel (DE-588)4003115-9 gnd |
| topic_facet | Drug development Pharmaceutical technology Drugs Law and legislation Pharmaceutical industry Drug Industry organization & administration Chemistry, Pharmaceutical Drug Compounding Legislation, Drug Legislation, Pharmacy Zulassung Arzneimittelentwicklung Arzneimittel |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=030137579&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV000002008 |
| work_keys_str_mv | AT nusimstanleyh activepharmaceuticalingredientsdevelopmentmanufacturingandregulation |